Global Auto-Injectors Market Size, Share, Development, Growth and Demand Forecast to 2023

  • ID: 4340297
  • Report
  • Region: Global
  • 130 pages
  • P&S Market Research
1 of 3
Market Overview

Auto-injectors refer to a pen like medical device used for injecting a specific dose of drugs to patients. They are spring-loaded syringes that are especially designed for safe administration of the drugs with ease. These offer various added features over other traditional devices, which were not user friendly and led to frequent visits to doctors. The two types of auto-injectors currently available in market are prefilled and fillable. The prefilled auto-injectors has been the larger segment in the global auto-injectors market.

Based on manufacturing design, the global market is classified into the standardized auto-injectors and customized auto-injectors. Standardized auto-injectors held the larger share in the global auto-injectors market in 2016.Standardized injectors are designed to be easily assembled and perform the self-administration process of drugs without altering the primary packaging, using automated pathways, which further reduces the chances of accidental injuries and dose errors. These products find therapeutic application in treating anaphylaxis, multiple sclerosis, rheumatoid arthritis and other diseases, where anaphylaxis has been the largest therapeutic application area of auto-injectors and drives the growth of auto-injectors market.

Market Dynamics

The global auto-injectors market is expected to witness a CAGR of 18.6% during the forecast period (2017 - 2023). Rising prevalence of anaphylaxis and increasing healthcare spending are some of the key drivers for the global market growth. Additionally, emerging biologic drug therapies, minimized needle-stick injuries and growing aging population also support the growth of the global market. On the other hand, the auto-injectors market has been facing certain challenges such as high cost of auto-injectors, leading to low adherence and stringent regulatory requirements, which may impede its growth during the forecast period. Moreover, shifting interest of consumers from hospital to home for their healthcare needs is a key trend observed in the global auto-injectors market.

Opportunities

The increasing demand and penetration of auto-injectors in emerging economies offers enormous growth opportunities for the global auto-injectors market. With high economic growth and increasing government initiatives in Asia-Pacific, the major auto-injectors manufacturers are penetrating into the untapped market in the region.

Countries such as China and India have a huge growth potential for the auto-injectors market during the forecast years. The growth is expected to be driven by the increasing healthcare awareness, rising healthcare spending and regulatory initiatives for preventing needle-stick injuries. The countries, such as China, Brazil and India have a large population base but they still lack primary healthcare facilities. The incidence rates of various allergies are high in these countries, mainly due to lack of awareness. However, various initiatives have been taken globally to create healthcare awareness and accelerate the adoption rate of auto-injectors in the Asia-Pacific region. Prefilled and fillable auto-injectors play a vital role in treating various diseases such as, anaphylaxis, multiple sclerosis, rheumatoid arthritis and other diseases. Therefore, ease of healthcare access in these countries can create ample growth opportunities for the global market.

Growth Drivers

Needle-stick injury during drug administration can lead to blood-borne pathogen transmission, therefore healthcare workers can experience anxiety, fear and emotional distress. This risk associated with the use of the needle-stick is reduced by using auto-injectors. According to World Health Organization (WHO), approximately 16 billion injections are administered every year, globally; however, most of the syringes and needles are not properly disposed.

Similarly, according to WHO, every year unsafe injection causes approximately 1.3 million early deaths. The healthcare industry in various countries is following the mandatory use of devices with needle-stick prevention features. The increasing awareness about accidental needle-stick injuries is leading to increased emphasis on occupational safety. The innovation for safety from needle-stick is the major concern for regulatory bodies, since the number of logged needle-stick injuries in healthcare workers is on a rise. Therefore, new regulation in various regions would mandate the complete use of safety syringe to prevent needle-stick injuries. For instance, WHO hosts and coordinates the Safe Injection Global Network (SIGN), to promote and sustain injection safety worldwide. The increase in awareness about needle-stick injury leads to increased adoption of auto-injectors globally.

The self-administration drugs are mainly used for the treatment of rheumatoid arthritis, diabetes, multiple sclerosis and others. The demand for self-injection has been increasing, in order to reduce appointments and home visits, which acts as cost saver for healthcare authorities. Additionally, the usage of auto-injectors has decreased the overall medical expenses of the patient, which includes clinics visit for every injection.

The increasing number of diabetes patients would increase the number of people using self-injecting drugs. According to the World Health Organization (WHO), globally 422 million adults were living with diabetes in 2014. With an increase in number of cases for diabetes, the use of auto-injectors is expected to increase significantly. Auto-injectors are commonly used for home based treatment for major therapeutic areas, such as anaphylaxis, rheumatoid arthritis, multiple sclerosis and other diseases. The increasing awareness about various added features offered by auto-injectors leads to its increased adoption, driving the growth of the global market.

Competitive Landscape

Key player in the auto-injectors market are collaborating and acquiring other players to offer more advance solutions for treating anaphylaxis, multiple sclerosis and rheumatoid arthritis and other diseases. In March 2017, Eli Lilly and Company announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. The tender offer for all outstanding shares of common stock of CoLucid, at a price of $46.50 per share, expired on 28 February 2017. This acquisition will expand the Lilly’s existing pain management portfolio by adding lasmiditan for the acute treatment of migraine.

Some of the key players operating in the global market include Mylan N.V., Antares Pharma Inc., Becton, Dickinson & Company, Eli Lilly and Company, Pfizer, Inc., Bayer AG, Novartis International AG, Bristol-Myer Squibb, Novartis AG, Amgen Inc. and Biogen Inc.

Scope for Customization

Customization is offered as per specific business requirements of clients. Illustrative customization within the scope of this report includes:
  • Period of Analysis - Increase in the study period, including historic and forecast years
  • Geographical Analysis - Increase in country coverage
  • Segment Analysis - More granular coverage related to:
  • Further analysis of product, manufacturing design and therapeutic application under auto-injectors by region
  • Company Profiles - Wider company coverage in terms of detailed analysis or additional company profiles
  • New custom report - A completely customized report can be provided on the market, specific to a region/ country/ segment
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation By Product
1.3.2 Market Segmentation By Manufacturing Design
1.3.3 Market Segmentation By Therapeutic Application
1.3.4 Market Segmentation By Geography
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.3.6.1 Value
1.4 Key Stakeholders

2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown Of Primary Research Respondents
2.2.1.1 By Region
2.2.1.2 By Industry Participant
2.2.1.3 By Company Type
2.3 Market Size Estimation
2.4 Market Breakdown And Data Triangulation
2.5 Assumptions For The Study

3. Executive Summary
3.1 Key Findings
3.2 Research Summary

4. Introduction
4.1 Market Segmentation
4.1.1 Overview By Product
4.1.1.1 Prefilled Auto-Injectors
4.1.1.2 Fillable Auto-Injectors
4.1.2 Overview By Manufacturing Design
4.1.2.1 Standardized Auto-Injectors
4.1.2.2 Customized Auto-Injectors
4.1.3 Overview By Therapeutic Application
4.1.3.1 Anaphylaxis
4.1.3.2 Multiple Sclerosis
4.1.3.3 Rheumatoid Arthritis
4.1.3.4 Others
4.2 Market Dynamics
4.2.1 Trend
4.2.1.1 Healthcare From Hospital To Home
4.2.2 Drivers
4.2.2.1 Rising Prevalence Of Anaphylaxis
4.2.2.2 Increasing Healthcare Spending
4.2.2.3 Emerging Biologic Drug Therapies
4.2.2.4 Minimized Needle-Stick Injuries
4.2.2.5 Growing Aging Population
4.2.2.6 Impact Analysis Of Drivers On Market Forecast
4.2.3 Restraints
4.2.3.1 High Cost Leading To Low Adherence
4.2.3.2 Stringent Regulatory Requirements
4.2.3.3 Impact Analysis Of Restraints On Market Forecast
4.2.4 Opportunity
4.2.4.1 Penetration In Emerging Economies
4.3 Porter's Five Forces Analysis
4.3.1 Bargaining Power Of Buyer
4.3.2 Bargaining Power Of Suppliers
4.3.3 Threat Of New Entrants
4.3.4 Intensity Of Rivalry
4.3.5 Threat Of Substitutes

5. Market Size And Forecast By Product
5.1 Global Prefilled Auto-Injectors Market
5.1.1 Global Prefilled Auto-Injectors Market, By Region
5.2 Global Fillable Auto-Injectors Market
5.2.1 Global Fillable Auto-Injectors Market, By Region

6. Market Size And Forecast By Manufacturing Design
6.1 Global Standardized Auto-Injectors Market
6.1.1 Global Standardized Auto-Injectors Market, By Region
6.2 Global Customized Auto-Injectors Market
6.2.1 Global Customized Auto-Injectors Market, By Region

7. Market Size And Forecast By Therapeutic Application
7.1 Global Auto Injector Market For Anaphylaxis
7.1.1 Global Auto-Injectors Market For Anaphylaxis, By Region
7.2 Global Auto Injector Market For Multiple Sclerosis
7.2.1 Global Auto-Injectors Market For Multiple Sclerosis, By Region
7.3 Global Auto Injector Market For Rheumatoid Arthritis
7.3.1 Global Auto-Injectors Market For Rheumatoid Arthritis, By Region

8. Market Size And Forecast By Geography
8.1 North America Auto-Injectors Market
8.1.1 North America Auto-Injectors Market By Product
8.1.2 North America Auto-Injectors Market By Manufacturing Design
8.1.3 North America Auto-Injectors Market By Therapeutic Application
8.1.4 North America Auto-Injectors Market By Country
8.2 Europe Auto-Injectors Market
8.2.1 Europe Auto-Injectors Market, By Product
8.2.2 Europe Auto-Injectors Market, By Manufacturing Design
8.2.3 Europe Auto-Injectors Market, By Therapeutic Application
8.2.4 Europe Auto-Injectors Market, By Country
8.3 Asia-Pacific (Apac) Auto-Injectors Market
8.3.1 Apac Auto-Injectors Market, By Product
8.3.2 Apac Auto-Injectors Market, By Manufacturing Design
8.3.3 Apac Auto-Injectors Market, By Therapeutic Application
8.3.4 Apac Auto-Injectors Market, By Country
8.4 Latin America (Latam) Auto-Injectors Market
8.4.1 Latam Auto-Injectors Market, By Product
8.4.2 Latam Auto-Injectors Market, By Manufacturing Design
8.4.3 Latam Auto-Injectors Market, By Therapeutic Application
8.4.4 Latam Auto-Injectors Market, By Country
8.5 Middle East And Africa (Mea) Auto-Injectors Market
8.5.1 Mea Auto-Injectors Market, By Product
8.5.2 Mea Auto-Injectors Market, By Manufacturing Design
8.5.3 Mea Auto-Injectors Market, By Therapeutic Application

9. Competitive Landscape
9.1 Competitive Positioning Of Key Players In The Global Auto-Injectors Market
9.2 Global Strategic Developments
9.2.1 Product Launch And Approval
9.2.2 Partnership And Collaboration
9.2.3 Others

10. Company Profiles
10.1 Mylan N.V.
10.1.1 Business Overview
10.1.2 Product And Service Offerings
10.2 Antares Pharma Inc.
10.2.1 Business Overview
10.2.2 Products And Service Offerings
10.3 Becton, Dickinson And Company
10.3.1 Business Overview
10.3.2 Products And Service Offerings
10.4 Eli Lilly And Company
10.4.1 Business Overview
10.4.2 Product And Service Offerings
10.5 Pfizer Inc.
10.5.1 Business Overview
10.5.2 Product And Service Offerings
10.5.3 Strategic Growth Plans
10.6 Bayer Ag
10.6.1 Business Overview
10.6.2 Product And Service Offerings
10.6.3 Strategic Growth Plans
10.7 Bristol- Myer Squibb
10.7.1 Business Overview
10.7.2 Product And Service Offerings
10.7.3 Strategic Growth Plans
10.8 Novartis Ag
10.8.1 Business Overview
10.8.2 Product And Service Offerings
10.8.3 Strategic Growth Plans
10.9 Amgen Inc.
10.9.1 Business Overview
10.9.2 Product And Service Offerings
10.9.3 Strategic Growth Plans
10.1 Biogen Inc.
10.10.1 Business Overview
10.10.2 Product And Service Offerings

11. Appendix
11.1 Abbreviations

List Of Tables
Table 1 Analysis Period Of The Study
Table 2 Global Auto-Injectors Market Snapshot
Table 3 Healthcare Expenditure As % Of Gdp
Table 4 Drivers For The Market: Impact Analysis
Table 5 Restraints For The Market: Impact Analysis
Table 6 Global Auto-Injectors Market, By Product, $M (2013 - 2016)
Table 7 Global Auto-Injectors Market, By Product, $M (2017 - 2023)
Table 8 Global Prefilled Auto-Injectors Market, By Region, $M (2013 - 2016)
Table 9 Global Prefilled Auto-Injectors Market, By Region, $M (2017 - 2023)
Table 10 Global Fillable Auto-Injectors Market, By Region, $M (2013 - 2016)
Table 11 Global Fillable Auto-Injectors Market, By Region, $M (2017 - 2023)
Table 12 Global Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2016)
Table 13 Global Auto-Injectors Market, By Manufacturing Design, $M (2017 - 2023)
Table 14 Global Standardized Auto-Injectors Market, By Region, $M (2013 - 2016)
Table 15 Global Standardized Auto-Injectors Market, By Region, $M (2017 - 2023)
Table 16 Global Customized Auto-Injectors Market, By Region, $M (2013 - 2016)
Table 17 Global Customized Auto-Injectors Market, By Region, $M (2017 - 2023)
Table 18 Global Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2016)
Table 19 Global Auto-Injectors Market, By Therapeutic Application, $M (2017 - 2023)
Table 20 Global Auto-Injectors Market For Anaphylaxis, By Region, $M (2013 - 2016)
Table 21 Global Auto-Injectors Market For Anaphylaxis, By Region, $M (2017 - 2023)
Table 22 Global Auto-Injectors Market For Multiple Sclerosis, By Region, $M (2013 - 2016)
Table 23 Global Auto-Injectors Market For Multiple Sclerosis, By Region, $M (2017 - 2023)
Table 24 Global Auto-Injectors Market For Rheumatoid Arthritis, By Region, $M (2013 - 2016)
Table 25 Global Auto-Injectors Market For Rheumatoid Arthritis, By Region, $M (2017 - 2023)
Table 26 North America Auto-Injectors Market, By Product, $M (2013 - 2016)
Table 27 North America Auto-Injectors Market, By Product, $M (2017- 2023)
Table 28 North America Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2016)
Table 29 North America Auto-Injectors Market, By Manufacturing Design, $M (2017 - 2023)
Table 30 North America Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2016)
Table 31 North America Auto-Injectors Market, By Therapeutic Application, $M (2017 - 2023)
Table 32 North America Auto-Injectors Market, By Country, $M (2013 - 2016)
Table 33 North America Auto-Injectors Market, By Country, $M (2017 - 2023)
Table 34 Europe Auto-Injectors Market, By Product, $M (2013 - 2016)
Table 35 Europe Auto-Injectors Market, By Product, $M (2017 - 2023)
Table 36 Europe Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2016)
Table 37 Europe Auto-Injectors Market, By Manufacturing Design, $M (2017 - 2023)
Table 38 Europe Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2023)
Table 39 Europe Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2016)
Table 40 Europe Auto-Injectors Market, By Therapeutic Application, $M (2017 - 2023)
Table 41 Europe Auto-Injectors Market, By Country, $M (2013 - 2016)
Table 42 Europe Auto-Injectors Market, By Country, $M (2017 - 2023)
Table 43 Top Apac Countries In R&D Spending
Table 44 Apac Auto-Injectors Market, By Product, $M (2013 - 2016)
Table 45 Apac Auto-Injectors Market, By Product, $M (2017 - 2023)
Table 46 Apac Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2016)
Table 47 Apac Auto-Injectors Market, By Manufacturing Design, $M (2017 - 2023)
Table 48 Apac Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2016)
Table 49 Apac Auto-Injectors Market, By Therapeutic Application, $M (2016 -2023)
Table 50 Apac Auto-Injectors Market, By Country, $M (2013 - 2016)
Table 51 Apac Auto-Injectors Market, By Country, $M (2017 - 2023)
Table 52 Latam Auto-Injectors Market, By Product, $M (2013 - 2016)
Table 53 Latam Auto-Injectors Market, By Product, $M (2017 - 2023)
Table 54 Latam Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2016)
Table 55 Latam Auto-Injectors Market, By Manufacturing Design, $M (2017 - 2023)
Table 56 Latam Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2016)
Table 57 Latam Auto-Injectors Market, By Therapeutic Application, $M (2017 - 2023)
Table 58 Latam Auto-Injectors Market, By Country, $M (2013 - 2016)
Table 59 Latam Auto-Injectors Market, By Country, $M (2016 - 2023)
Table 60 Mea Auto-Injectors Market, By Product, $M (2013 - 2016)
Table 61 Mea Auto-Injectors Market, By Product, $M (2017 - 2023)
Table 62 Mea Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2016)
Table 63 Mea Auto-Injectors Market, By Manufacturing Design, $M (2017 - 2023)
Table 64 Mea Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2023)
Table 65 Mea Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2016)
Table 66 Mea Auto-Injectors Market, By Therapeutic Application, $M (2017 - 2023)
Table 67 Mylan N.V.- At A Glance
Table 68 Antares Pharma Inc.- At A Glance
Table 69 Becton, Dickinson And Company - At A Glance
Table 70 Eli Lilly And Company- At A Glance
Table 71 Pfizer Inc. - At A Glance
Table 72 Bayer Ag- At A Glance
Table 73 Bristol- Myer Squibb- At A Glance
Table 74 Novartis Ag - At A Glance
Table 75 Amgen- At A Glance
Table 76 Biogen Inc- At A Glance

List Of Figures
Fig 1 Research Scope For Global Auto-Injectors Market
Fig 2 Research Methodology For The Global Auto-Injectors Market
Fig 3 Regional Split Of Primary And Secondary Research
Fig 4 Breakdown Of Primary Research By Region
Fig 5 Breakdown Of Primary Research By Industry Participant
Fig 6 Breakdown Of Primary Research By Company Type
Fig 7 Data Triangulation Approach For The Global Auto-Injectors Market
Fig 8 Aging Population As A Percentage Of Total Population
Fig 9 Porters Five Forces Analysis For Global Auto-Injectors Market
Fig 10 Global Auto-Injectors Market Snapshot
Fig 11 Global Auto-Injectors Market, By Product, $M (2013 - 2023)
Fig 12 Global Prefilled Auto-Injectors Market, By Region, $M (2013 - 2023)
Fig 13 Global Fillable Auto-Injectors Market, By Region, $M (2013 - 2023)
Fig 14 Global Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2023)
Fig 15 Global Standardized Auto-Injectors Market, By Region, $M (2013 - 2023)
Fig 16 Global Customized Auto-Injectors Market, By Region, $M (2013 - 2023)
Fig 17 Global Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2023)
Fig 18 Global Auto-Injectors Market For Anaphylaxis, By Region, $M (2013 - 2023)
Fig 19 Global Auto-Injectors Market For Multiple Sclerosis, By Region, $M (2013 - 2023)
Fig 20 Global Auto-Injectors Market For Rheumatoid Arthritis, By Region, $M (2013 - 2023)
Fig 21 Worldwide Major Markets For Auto-Injectors (2023)
Fig 22 North America Auto-Injectors Market Snapshot
Fig 23 North America Auto-Injectors Market, By Product, $M (2013 - 2023)
Fig 24 North America Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2023)
Fig 25 North America Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2023)
Fig 26 North America Auto-Injectors Market, Country, $M (2013 - 2023)
Fig 27 Europe Auto-Injector Market Snapshot
Fig 28 Europe Auto-Injectors Market, By Product, $M (2013 - 2023)
Fig 29 Europe Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2023)
Fig 30 Europe Auto-Injectors Market, By Country, $M (2013 - 2023)
Fig 31 Asia-Pacific Auto-Injetors Market Snapshot
Fig 32 Apac Auto-Injectors Market, By Product, $M (2013-2023)
Fig 33 Apac Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2023)
Fig 34 Apac Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2023)
Fig 35 Apac Auto-Injectors Market, By Country, $M (2013 - 2023)
Fig 36 Latam Auto-Injectors Market Snapshot
Fig 37 Latam Auto-Injectors Market, By Product, $M (2013 - 2023)
Fig 38 Latam Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2023)
Fig 39 Latam Auto-Injectors Market, By Therapeutic Application, $M (2013 - 2023)
Fig 40 Latam Auto-Injectors Market, By Country, $M (2013 - 2023)
Fig 41 Mea Auto-Injectors Market Snapshot
Fig 42 Mea Auto-Injectors Market, By Product, $M (2013 - 2023)
Fig 43 Mea Auto-Injectors Market, By Manufacturing Design, $M (2013 - 2023)
Fig 44 Competitive Positioning Of Key Players In The Global Auto-Injectors Market (2016)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll